7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.5.1
GHRP-2
Growth Hormone Releasing Peptide-2, Pralmorelin, KP-102
Cat 2 restricted

No. Not currently eligible for pharmacy compounding.

Talk to a licensed clinician before acting on this.

503A Category 3 (no adequate support); 503B Category 2 for injectable/nasal routes

Hormonal
Sources: FDA · FDA · FDA

Same category

Related peptides

PEG-MGFRemoved from Cat 2CJC-1295Not 503A eligibleIpamorelinCat 2 restrictedSermorelinFDA approved

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.

Verify a pharmacy See fair pricing